Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling

Journal of Clinical Oncology

Volumn 23, Issue 9, 2005, Pages 1927-1933

  Sudbø, Jon ^a   Samuelsson, Roy ^a   Risberg, Björn ^a   Heistein, Stig ^a   Nyhus, Christian ^a   Samuelsson, Margaretha ^a   Puntervold, Ruth ^a   Sigstad, Eva ^a   Davidson, Ben ^a   Reith, Albrecht ^a   Berner, Åsmund ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; TUMOR MARKER;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BEHAVIOR THERAPY; CANCER RISK; CONTROLLED STUDY; CYTOLOGY; DEMOGRAPHY; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LEUKOPLAKIA; MALE; MOUTH CANCER; MOUTH MUCOSA; PATIENT COUNSELING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING CESSATION; SMOKING HABIT; TETRAPLOIDY; CHROMOSOME ANALYSIS; COUNSELING; GENETICS; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PLOIDY; PROSPECTIVE STUDY; SMOKING;

ADULT; BEHAVIOR THERAPY; COUNSELING; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PLOIDIES; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; TUMOR MARKERS, BIOLOGICAL;

EID: 20144363562     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.172     Document Type: Article

References (43)

1. Day TA, Davis BK, Gillespie MB, et al: Oral cancer treatment. Curr Treat Options Oncol 4:27-41, 2003
2. Reibel J: Tobacco and oral diseases: Update on the evidence, with recommendations. Med Princ Pract 12:22-32, 2003 (suppl 1)
3. Das BR, Nagpal JK: Understanding the biology of oral cancer. Med Sci Monit 8:258-267, 2002
4. Johnson NW, Bain CA: Tobacco and oral disease: EU-Working Group on Tobacco and Oral Health. Br Dent J 189:200-206, 2000
5. Johnson N: Oral cancer: Practical prevention. FDI World 6:10-16, 1997
6. Browning KK, Wewers ME: Smoking cessation and cancer. Semin Oncol Nurs 19:268-275, 2003
7. Reichart PA: Identification of risk groups for oral precancer and cancer and preventive measures. Clin Oral Invest 5:207-213, 2001
8. Sankaranarayanan R: Health care auxiliaries in the detection and prevention of oral cancer. Oral Oncol 33:149-154, 1997
9. Tingle LR, DeSimone M, Covington B: A meta-evaluation of 11 school-based smoking prevention programs. J Sch Health 73:64-67, 2003
10. Gray N: The ethics of policies for the prevention of tobacco disease. Acta Oncol 43:8-10, 2004
11. Keller S, Donner-Banzhoff N, Kaluza G, et al: Improving physician-delivered counseling in a primary care setting: Lessons from a failed attempt. Educ Health (Abingdon) 13:387-397, 2000
12. Shain RN, Piper JM, Newton ER, et al: A randomized, controlled trial of a behavioral intervention to prevent sexually transmitted disease among minority women. N Engl J Med 340:93-100, 1999
13. Edwards A, Unigwe S, Elwyn G, et al: Effects of communicating individual risks in screening programmes: Cochrane systematic review. BMJ 327:703-709, 2003
14. Sudbø J, Kildal W, Risberg B, et al: DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 344:1270-1278, 2001
15. Sudbø J, Lippman SM, Lee JJ, et al: The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 350:1405-1413, 2004
16. Sudbø J, Kildal W, Johannessen AC, et al: Gross genomic aberrations in precancers: Clinical implications of a long-term follow-up study in oral erythroplakias. J Clin Oncol 20:456-462, 2002
17. Sudbø J, Ried T, Bryne M, et al: Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. Oral Oncol 37:558-565, 2001
18. Mao L, EI-Naggar AK, Fan YH, et al: Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 56:5600-5604, 1996
19. Mao L, Lee JS, Fan YH, et al: Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2:682-685, 1996
20. Ai H, Barrera JE, Meyers AD, et al: Chromosomal aneuploidy precedes morphological changes and supports multifocality in head and neck lesions. Laryngoscope 111:1853-1858, 2001
21. Barrera JE, Miller ME, Said S, et al: Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope 113:892-896, 2003
22. Greenspan D, Jordan RC: The white lesion that kills: Aneuploid dysplastic oral leukoplakia. N Engl J Med 350:1382-1384, 2004
23. Remmerbach TW, Weidenbach H, Pomjanski N, et al: Cytologic and DNA-cytometric early diagnosis of oral cancer. Anal Cell Pathol 22:211-221, 2001
24. Sen S: Aneuploidy and cancer. Curr Opin Oncol 12:82-88, 2000
25. Bocking A, Giroud F, Reith A: Consensus report of the ESACP task force on standardization of diagnostic DNA image cytometry: European Society for Analytical Cellular Pathology. Anal Cell Pathol 8:67-74, 1995
26. Haroske G, Giroud F, Reith A, et al: 1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: Basic considerations and recommendations for preparation, measurement and interpretation-European Society for Analytical Cellular Pathology. Anal Cell Pathol 17:189-200, 1998
27. Haroske G, Baak JP, Danielsen H, et al: Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol 23:89-95, 2001
28. Mork J, Lie AK, Glattre E, et al: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125-1131, 2001
29. Waldron CA, Shafer WG: Leukoplakia revisited: A clinicopathologic study 3256 oral leukoplakias. Cancer 36:1386-1392, 1975
30. Suchanek HK, Kroon LA, Corelli RL, et al: Training future pharmacists at a minority educational institution: Evaluation of the Rx for change tobacco cessation training program. Cancer Epidemiol Biomarkers Prev 13:477-481, 2004
31. Hollis JF, Lichtenstein E, Vogt TM, et al: Nurse-assisted counseling for smokers in primary care. Ann Intern Med 118:521-525, 1993
32. Gritz ER, Carmack CL, de Moor C, et al: First year after head and neck cancer: Quality of life. J Clin Oncol 17:352-360, 1999
33. Rice V, Stead L: Nursing interventions for smoking cessation. [Cochrane Database System Review]. Oxford, England, Cochrane Library, CD001188, issue 1, 2004
34. Johnson NW: The role of the dental team in tobacco cessation. Eur J Dent Educ 8:18-24, 2004 (suppl 4)
35. Gritz ER, Schacherer C, Koehly L, et al: Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 21:420-427, 1999
36. Hafstad A, Aaro LE, Engeland A, et al: Provocative appeals in anti-smoking mass media campaigns targeting adolescents-the accumulated effect of multiple exposures. Health Educ Res 12:227-236, 1997
37. Dempsey DA, Benowitz NL: Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 24:277-322, 2001
38. Abdel-Salam M, Mayall BH, Chew K, et al: Which oral white lesions will become malignant? An image cytometric study. Oral Surg Oral Med Oral Pathol 69:345-350, 1990
39. Abdel-Salam M, Mayall BH, Chew K, et al: Prediction of malignant transformation in oral epithelial lesions by image cytometry. Cancer 62:1981-1987, 1988
40. Högmo A, Munck-Wikland E, Kuylenstierna R, et al: Nuclear DNA content and p53 immunostaining in metachronous preneoplastic lesions and subsequent carcinomas of the oral cavity. Head Neck 18:433-440, 1996
41. Gritz ER, Carr CR, Rapkin D, et al: Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 2:261-270, 1993
42. Purkis PE, Steel JB, Mackenzie IC, et al: Antibody markers of basal cells in complex epithelia. J Cell Sci 97:39-50, 1990
43. Bickenbach JR, McCutecheon J, Mackenzie IC: Rate of loss of tritiated thymidine label in basal cells in mouse epithelial tissues. Cell Tissue Kinet 19:325-333, 1986